Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00087880 · ClinicalTrials.gov registry record · Phase 2

Maintaining Abstinence in Chronic Cigarette Smokers - 1

A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
Phase 2
Development phase
407
Enrollment target

NCT00087880: Completed Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).

NCT00087880 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 407 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (206% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00087880, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
Phase 2
Development phase
407 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the extended pharmacological and psychological treatment for chronic cigarette smokers.

Interventions

  • DRUG Bupropion and NRT

Trial Details

FieldValue
Enrollment Target 407 participants
Start Date 2002-12
Est. Completion 2009-09
Phase Phase 2

What the finished NCT00087880 record still lists

NCT00087880 is an interventional study that assigns participants to a tested intervention. The registered 407 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (206% higher).

The record links to 0 conditions, and to 1 intervention - of which Bupropion and NRT is the first listed.

NCT00087880 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00087880 about?

NCT00087880 is a clinical study titled "Maintaining Abstinence in Chronic Cigarette Smokers - 1". The purpose of this study is to evaluate the extended pharmacological and psychological treatment for chronic cigarette smokers.

What is the current status of trial NCT00087880?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 407 participants. The study started on 2002-12. Estimated completion is 2009-09.

What interventions are being tested in trial NCT00087880?

The interventions under investigation include: Bupropion and NRT (DRUG).

Who is sponsoring clinical trial NCT00087880?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00087880's enrollment target sits among peer trials

407 93rd of 2000 higher than 1,907 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06735534 · 407 participants · NA

    Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

  • NCT07094516 · 407 participants · Phase 2

    A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  • NCT04835428 · 408 participants · NA

    STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures

  • NCT05836324 · 408 participants · Phase 1

    A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00087880, the US trial registry maintained by the National Library of Medicine. NCT00087880 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.